Patient smiling at a doctor.

Oncology and social factors

Based on clinical evidence, we know that oncology patients facing financial security, food security, social isolation, housing security, addiction and other issues are prone to worse outcomes than patients without these challenges.

Oncologists share their views

by Will Seaton

More than 160 oncologists voice their opinions on important topics affecting physicians, such as MACRA and physician burnout.

New research explores oncologists' views on precision medicine

by Will Seaton

Precision medicine has the potential to transform cancer care, but challenges need to be addressed. Here’s what more than 160 oncologists nationwide said about their aspirations and hesitations for these targeted therapies.

3 key insights from oncologists on emerging therapies

by Will Seaton

Recent medical advancements may change cancer care. New research explores oncologists' views on CAR T-Cell therapy, biosimilars and AML therapies.

*
*
Yes, I would like to learn more about Cardinal Health’s products and services by email. I can withdraw my consent or change my preferences by visiting Update Preferences. Visit Privacy Policy for more information about Cardinal Health’s privacy practices.

New research: 3 key insights from oncologists

by Will Seaton

Oncology care has never been more complex. Our recent research provides deeper insights into how important issues are viewed by providers nationally.

Bringing precision medicine into focus

by Will Seaton

Precision medicine is an emerging approach for disease treatment. Our experts look at where it currently stands and what’s on the horizon.

Managing the complexity of outpatient oncology care

by Chadi Nabhan

Approximately 1.8 million new cancer cases are detected annually, and the majority of cancer patients remain alive five years after diagnosis, underscoring the need for proper coordination of care.

Latest specialty care research

by Bruce Feinberg

Latest findings on specialty care using real-world data

Value-based care and HEOR

by Jennifer Fillman

Why manufacturers should leverage economics outcomes research to provide real-world evidence of the total value their specialty medications can deliver.

of 3 remaining articles
*
*
Yes, I would like to learn more about Cardinal Health’s products and services by email. I can withdraw my consent or change my preferences by visiting Update Preferences. Visit Privacy Policy for more information about Cardinal Health’s privacy practices.